"Thromboxane B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).
Descriptor ID |
D013929
|
MeSH Number(s) |
D10.251.355.255.100.825.810 D10.251.355.310.166.971.810
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thromboxane B2".
Below are MeSH descriptors whose meaning is more specific than "Thromboxane B2".
This graph shows the total number of publications written about "Thromboxane B2" by people in this website by year, and whether "Thromboxane B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 4 | 1 | 5 |
2018 | 2 | 3 | 5 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Thromboxane B2" by people in Profiles.
-
Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease. Circ Res. 2020 09 11; 127(7):945-947.
-
Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss. Nutrients. 2018 Dec 02; 10(12).
-
Development and validation of a liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of serotonin and thromboxane B2 from activated platelets. Int J Lab Hematol. 2018 Dec; 40(6):663-671.
-
Panax quinquefolius saponins combined with dual antiplatelet drug therapy alleviate gastric mucosal injury and thrombogenesis through the COX/PG pathway in a rat model of acute myocardial infarction. PLoS One. 2018; 13(3):e0194082.
-
Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia. Pharmacol Res. 2018 05; 131:66-74.
-
Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium. J Thromb Thrombolysis. 2018 Jan; 45(1):18-26.
-
Prognostic value of urinary 11-dehydro-thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirin. Catheter Cardiovasc Interv. 2018 10 01; 92(4):653-658.
-
Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2017 Sep 19; 70(12):1455-1462.
-
Application of Metabolic Profiling to Abdominal Aortic Aneurysm Research. J Proteome Res. 2017 07 07; 16(7):2325-2332.
-
Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease. Coron Artery Dis. 2017 Jun; 28(4):287-293.